Development Level

Tbio 2 | 10,625
Tclin 1 | 602

Disease

Cancer 3 | 2,346
lung cancer 2 | 4,466
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,484
psoriasis 2 | 6,685
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V 1 | 1
Addison's disease 1 | 29
Adult T-Cell Lymphoma/Leukemia 1 | 30
Allergic hypersensitivity disease 1 | 123
Alopecia areata 1 | 37
Anemia 1 | 252
Asthma 1 | 349
Atopic dermatitis 1 | 944
Autoimmune thyroiditis 1 | 24
Breast cancer 1 | 3,094
CD59 Deficiency 1 | 1
CELIAC DISEASE, SUSCEPTIBILITY TO, 3 (finding) 1 | 1
Celiac disease 1 | 112
Colitis 1 | 46
Congenital hemolytic anemia 1 | 30
DIABETES MELLITUS, INSULIN-DEPENDENT, 12 1 | 1
Dermatitis 1 | 107
Diabetes Mellitus, Insulin-Dependent 1 | 76
Diarrhea 1 | 155
Down syndrome 1 | 548
Exanthem 1 | 39
Graft-vs-Host Disease 1 | 5
Graves Disease 1 | 17
Graves' disease 1 | 25
Hashimoto Disease 1 | 2
Hepatitis B 1 | 103
Human immunodeficiency virus infectious disease 1 | 92
Hypersensitivity reaction type II disease 1 | 235
Hypothyroidism 1 | 89
Influenza 1 | 142
Juvenile arthritis 1 | 124
Liver disease 1 | 219
Lymphoma, T-Cell, Cutaneous 1 | 21
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2 1 | 3
Melanoma 1 | 261
Metastatic malignant melanoma 1 | 9
Multiple Sclerosis 1 | 498
Multiple myeloma 1 | 1,327
Oral Submucous Fibrosis 1 | 18
Peripheral Neuropathy 1 | 303
Postencephalitic Parkinson disease 1 | 1
Primary amebic meningoencephalitis 1 | 5
Proteinuria 1 | 63
Rheumatoid Arthritis 1 | 1,160
Thyroiditis 1 | 25
Thyrotoxicosis 1 | 38
Type 1 diabetes mellitus 1 | 101
Uveitis 1 | 103
Vascular disease 1 | 281
Vasculitis 1 | 64
acute myeloid leukemia 1 | 780
breast carcinoma 1 | 1,614
chronic lymphosyte leukemia 1 | 232
colon cancer 1 | 1,475
cutaneous lupus erythematosus 1 | 1,056
diabetes mellitus 1 | 1,663
esophageal adenocarcinoma 1 | 737
gastric cancer 1 | 430
glioblastoma 1 | 5,572
group 4 medulloblastoma 1 | 1,875
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
inflammatory breast cancer 1 | 404
interstitial cystitis 1 | 2,299
invasive ductal carcinoma 1 | 2,950
malignant mesothelioma 1 | 3,162
medulloblastoma, large-cell 1 | 6,234
pilocytic astrocytoma 1 | 3,086
primary Sjogren syndrome 1 | 789
spina bifida 1 | 1,064
systemic lupus erythematosus 1 | 156
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 3 | 11,971

Grant Application

1R41AI069865-01 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
CD59 glycoprotein CD59 Tbio Non-IDG -3.23780 1768.6 739
Cytotoxic T-lymphocyte protein 4 CTLA4 Tclin Non-IDG -3.46843 3564.0 656
Galectin-7 LGALS7B Tbio Non-IDG -2.78890 603.4 113